A general chemical principle for creating closure-stabilizing integrin inhibitors
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
SUMMARY Integrins are validated drug targets with six approved therapeutics. However, small molecule inhibitors to three integrins failed in late-stage clinical trials for chronic indications. Such unfavorable outcomes may in part be caused by partial agonism, i.e., stabilization of the high-affinity, extended-open integrin conformation. Here we show that failed, small molecule inhibitors of integrins αIIbβ3 and α4β1 stabilize the high-affinity conformation. Furthermore, we discovered a simple chemical feature present in multiple αIIbβ3 antagonists that stabilizes integrins in their bent-closed conformation. Closing inhibitors contain a polar nitrogen atom that stabilizes, via hydrogen bonds, a water molecule that intervenes between a serine residue and the metal in the metal ion-dependent adhesion site (MIDAS), expulsion of which is requisite for transition to the open conformation. This change in metal coordination is general to integrins, suggesting broad applicability of the drug-design principle to the integrin family, as validated with a distantly related integrin, α4β1.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Platelet Activation and Atherothrombosis
Davì, G., & Patrono, C. (2007) · New England Journal of Medicine · doi:10.1056/nejmra071014 · Cited by 2,135
Platelet Activation in Unstable Coronary Disease
Fitzgerald, D. J., Roy, L., Catella, F., & FitzGerald, G. A. (1986) · New England Journal of Medicine · doi:10.1056/nejm198610163151602 · Cited by 1,141
Structural insights into integrin α 5 β 1 opening by fibronectin ligand
Schumacher, S., Dedden, D., Nunez, R. V., Matoba, K., Takagi, J., Biertümpfel, C., & Mizuno, N. (2021) · Science Advances · doi:10.1126/sciadv.abe9716 · Cited by 150
Structural determinants of integrin β-subunit specificity for latent TGF-β
Dong, X., Hudson, N. E., Lu, C., & Springer, T. A. (2014) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2905 · Cited by 141
Self-citation
Cited by
Targeting integrin pathways: mechanisms and advances in therapy
Pang, X., He, X., Qiu, Z., Zhang, H., Xie, R., Liu, Z., Gu, Y., Zhao, N., Xiang, Q., & Cui, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01259-6 · Cited by 1,275
Cyclic Peptides for Drug Development
Ji, X., Nielsen, A. L., & Heinis, C. (2024) · Angewandte Chemie International Edition · doi:10.1002/anie.202308251 · Cited by 411
AlphaFold, allosteric, and orthosteric drug discovery: Ways forward
Nussinov, R., Zhang, M., Liu, Y., & Jang, H. (2023) · Drug Discovery Today · doi:10.1016/j.drudis.2023.103551 · Cited by 96
Ligand binding initiates single-molecule integrin conformational activation
Li, J., Jo, M. H., Yan, J., Hall, T., Lee, J., López-Sánchez, U., Yan, S., Ha, T., & Springer, T. A. (2024) · Cell · doi:10.1016/j.cell.2024.04.049 · Cited by 76
“32,33”
BackgroundMethodInfluentialSelf-citation
Metadata
- Authors
- Lin, F.-Y., Li, J., Xie, Y., Zhu, J., Huong Nguyen, T. T., Zhang, Y., Zhu, J., & Springer, T. A.
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2022-09
- Volume
- 185
- Issue
- 19
- Pages
- 3533-3550.e27
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W4295959779
- Cited by
- 57
- References
- 4
- FWCI
- 7.69
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.